- Report
- March 2024
- 186 Pages
Global
From €3242EUR$3,374USD£2,788GBP
€3602EUR$3,749USD£3,097GBP
- Report
- July 2023
- 130 Pages
Global
From €5717EUR$5,950USD£4,916GBP
- Report
- January 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- November 2023
- 181 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- July 2023
- 110 Pages
Global
From €4324EUR$4,500USD£3,718GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- April 2023
- 80 Pages
Vietnam
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
United States
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
United Kingdom
From €2493EUR$2,595USD£2,144GBP
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
South Korea
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
Saudi Arabia
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
Russia
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
Poland
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
Japan
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
Ireland
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
India
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
Germany
From €2493EUR$2,595USD£2,144GBP
- Report
- April 2023
- 80 Pages
France
From €2493EUR$2,595USD£2,144GBP
The Respiratory Disease Vaccine market is a subset of the larger Respiratory Drugs market. Vaccines are used to prevent the spread of respiratory diseases, such as influenza, pneumonia, and tuberculosis. Vaccines are typically administered to children and adults, and are often recommended for those at high risk of developing respiratory diseases. Vaccines are typically administered through injection, nasal spray, or oral drops.
The Respiratory Disease Vaccine market is highly competitive, with many companies offering a variety of vaccines. Companies in the market include Merck, GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. These companies are involved in the research, development, and production of vaccines for a variety of respiratory diseases. Additionally, many of these companies are involved in the distribution of vaccines to healthcare providers and pharmacies. Show Less Read more